R1	Has_qualifier Arg1:T1 Arg2:T2	
R2	Has_index Arg1:T3 Arg2:T4	
R3	Has_temporal Arg1:T1 Arg2:T3	
*	OR T13 T14
*	OR T11 T15
R4	Has_value Arg1:T10 Arg2:T12	
R5	Has_value Arg1:T8 Arg2:T9	
R6	Has_value Arg1:T5 Arg2:T7	
R7	Subsumes Arg1:T6 Arg2:T5	
*	OR T37 T38
*	OR T39 T40
R8	Has_value Arg1:T35 Arg2:T36	
R9	Has_value Arg1:T33 Arg2:T34	
R10	Has_value Arg1:T31 Arg2:T32	
R11	Has_value Arg1:T29 Arg2:T30	
R12	Has_value Arg1:T27 Arg2:T28	
R13	Has_value Arg1:T25 Arg2:T26	
R14	Has_value Arg1:T23 Arg2:T24	
R15	Has_value Arg1:T21 Arg2:T22	
R16	Has_value Arg1:T19 Arg2:T20	
*	OR T19 T25 T31
R17	Subsumes Arg1:T18 Arg2:T19	
R18	Has_value Arg1:T46 Arg2:T47	
*	OR T48 T50
R19	Has_negation Arg1:T48 Arg2:T49	
R20	Has_value Arg1:T10 Arg2:T13	
R21	Has_value Arg1:T10 Arg2:T11	
R22	Subsumes Arg1:T6 Arg2:T8	
R23	Subsumes Arg1:T6 Arg2:T10	
R24	Has_value Arg1:T35 Arg2:T37	
R25	Has_value Arg1:T35 Arg2:T39	
*	OR T21 T25 T31
*	OR T23 T25 T31
R28	Subsumes Arg1:T18 Arg2:T21	
R29	Subsumes Arg1:T18 Arg2:T23	
T1	Condition 22 45	prostate adenocarcinoma
T2	Qualifier 0 21	histologically proven
T3	Temporal 46 73	within 1 year of enrollment
T4	Reference_point 63 73	enrollment
T5	Measurement 85 92	Gleason
T6	Observation 75 83	Low risk
T7	Value 93 98	<or=6
T8	Measurement 101 104	PSA
T9	Value 105 111	<or=10
T10	Measurement 114 128	Clinical Stage
T12	Value 129 136	T1b-T2a
T13	Value 147 149	Mx
T14	Value 153 155	M0
T11	Value 137 139	Nx
T15	Value 143 145	N0
T18	Observation 157 174	Intermediate risk
T19	Measurement 175 182	Gleason
T20	Value 183 188	<or=6
T21	Measurement 191 194	PSA
T22	Value 194 200	<or=10
T23	Measurement 203 217	Clinical Stage
T24	Value 218 221	T2b
T25	Measurement 225 232	Gleason
T26	Value 232 234	=7
T27	Measurement 237 240	PSA
T28	Value 240 246	<or=10
T29	Measurement 249 263	Clinical Stage
T30	Value 264 271	T1b-T2b
T31	Measurement 275 282	Gleason
T32	Value 283 288	<or=6
T33	Measurement 291 294	PSA
T34	Value 295 310	> 10 & < or =20
T35	Measurement 313 327	Clinical Stage
T36	Value 328 336	T1b- T2b
T37	Value 338 340	Nx
T38	Value 344 346	NO
T39	Value 348 350	Mx
T40	Value 354 356	M0
T46	Measurement 358 381	ECOG Performance Status
T47	Value 382 385	0-1
T48	Procedure 396 414	prostate radiation
T49	Negation 387 389	No
T50	Procedure 424 442	definitive therapy
